Skip to main content
. 2015 Nov 13;2015(4):49. doi: 10.5339/gcsp.2015.49

Table 2.

Serum Biomarkers; Comparison between healthy and patients. MMP2: metalloproteinase 2; MMP9: metalloproteinase 9; TIMP1: tissue inhibitor 1 of metalloproteinase; TNFa: tumor necrosis factor a; TGFb1: transforming growth factor, beta 1; Ten C: Tenascin C; IL2: interleukin 2; Fet A: Fetuin A; SOST: Sclerostin; OPN: osteopontin; OPG: osteoprotegerin; RL2: Relaxin 2; MCP-1: monocyte chemoattractant protein 1; MDA: malondialdehyde. Results from serum biomarkers and TIMP1/MMP2 and TIMP1/MMP9 ratios between patients and healthy/controls tested with unpaired student t-test statistical analysis. Asterisk * represents p < 0.0001.

Healthy/Controls Patients p-value
Serum biomarkers (mean ± SD) (mean ± SD) Patients/Healthy
MMP2 (ng/ml) 169.3 ± 15.39 193.6 ± 48.49 0.03
MMP9 (ng/ml) 351 ± 30.29 464.3 ± 75.69 *
TIMP1 (ng/ml) 153.8 ± 32.63 106.7 ± 4.3 *
TIMP1/MMP2 0.91 ± 0.21 0.57 ± 0.1 *
TIMP1/MMP9 0.43 ± 0.089 0.23 ± 0.049 *
TNFa (ng/ml) 0.51 ± 0.29 17.06 ± 5.97 *
TGFβ1 (ng/ml) 0.136 ± 0.028 0.44 ± 0.12 *
Ten C (ng/ml) 48.24 ± 21.8 71.57 ± 25.7 0.0005
IL2 (ng/ml) 0.76 ± 0.2 1.57 ± 0.28 *
Fet A (ng/ml) 79.5 ± 7.68 48.05 ± 9 *
SOST (ng/ml) 0.6 ± 0.0.26 2.59 ± 0.79 *
OPN (ng/ml) 24.92 ± 3.5 58.53 ± 6.97 *
OPG (ng/ml) 6.71 ± 2.06 31.04 ± 13.67 *
RL2 (ng/ml) 0.5 ± 0.08 0.02 ± 0.005 *
MCP-1 (ng/ml) 0.015 ± 0.003 0.45 ± 0.21 *
MDA (ng/ml) 0.078 ± 0.008 2.076 ± 0.39 *